FLGT News and Press, Fulgent Genetics Inc. From 05/18/20

Sorrento Therapeutics (NASDAQ: SRNE ) +36%  in reaction to  reports  that it has discovered an antibody, dubbed STI-1499, that, it says, can provide 100% inhibition of COVID-19. More news on: Sorrento Therapeutics, Inc., Moderna, Inc., Fulgent Genetics, Inc., Stocks on the ...

TEMPLE CITY, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing solutions, today announced that its subsidiary, Fulgent Therapeutics, LLC, has received ...

The FDA has authorized the first at-home sample collection kit that can be used with multiple authorized COVID-19 lab tests. More news on: Fulgent Genetics, Inc., Healthcare stocks news, Read more ...

Gainers: Portola Pharmaceuticals (NASDAQ: PTLA ) +130% . More news on: Portola Pharmaceuticals, Inc., CleanSpark, Inc., Genprex, Inc., Stocks on the move, , Read more ...

Image source: The Motley Fool. Fulgent Genetics, Inc.   (NASDAQ: FLGT) Q1 2020 Earnings Call May 4, 2020 , 4:30 p.m. ET Operator Continue reading

Fulgent Genetics, Inc. (FLGT) Q1 2020 Earnings Conference Call May 04, 2020, 04:30 PM ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - CEO Paul Kim - CFO Brandon Perthuis - Chief Commercial Officer Conference Call Participants Erin Wright - Credit Suisse St...

Fulgent Genetics (NASDAQ: FLGT ): Q1 Non-GAAP EPS of -$0.03 misses by $0.05 ; GAAP EPS of -$0.09 misses by $0.06 . More news on: Fulgent Genetics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

TEMPLE CITY, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2020 financial results after the market closes on Monday May 4, 2020. The co...

TEMPLE CITY, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced that i...

Fulgent Genetics (FLGT) had a very good 2019, but it won't come as a surprise to realize that 2020 is going to be considerably more challenging. At the time of the Q4CC (March 10), the US was still a different place, so management did not see much impact of the coronavirus. In fact, they wer...